NCT05333237

Brief Summary

Perioperative fasting is an essential patient safety measure to reduce the risk of pulmonary aspiration of gastric contents, a rare but potentially catastrophic complication of anesthetic and airway management. Anesthesiologists' concern about aspiration and the increasing awareness towards the negative impact of prolonged restriction of oral intake have shaped the current fasting guidelines. However, due to the perceived safety of prolonged fasting and practical considerations, adoption of the fasting guidelines is suboptimal. Gastric ultrasound is a quick, non-invasive method to evaluate gastric contents and aspiration risk. Gastric ultrasound can accurately discriminate between solid particles and fluid content, and mathematical models can reliably predict the volume of the gastric contents from the gastric antral area (GAA). This project aims to use gastric ultrasound to provide new data that can support management strategies in perioperative patients, that ensure both a low aspiration risk and an adequate nutritional support. The investigators will test the hypothesis that commercially available liquid meals can be safely used preoperatively. A pilot crossover, study on healthy volunteers will be conducted to determine the gastric emptying time of high-calorie drinks, as compared to clear fluid.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

March 28, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 18, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2022

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

August 12, 2022

Status Verified

August 1, 2022

Enrollment Period

2 months

First QC Date

March 28, 2022

Last Update Submit

August 11, 2022

Conditions

Keywords

Preoperative fastingLiquid mealGastric ultrasound

Outcome Measures

Primary Outcomes (1)

  • Gastric emptying time

    Time since ingestion of any of the study products until an empty stomach can be determined on ultrasound

    Repeated ultrasound examinations will be performed every 30 minutes after the ingestion of the study product up to 6 hours after ingestion to determine whether the stomach has completely emptied.

Secondary Outcomes (1)

  • Gastric volume at prespecified intervals after ingestions

    Ultrasound examinations will be repeated every 30 minutes after the ingestion of the study product up to 6 hours and the gastric antrum area and the gastric antrum cross-sectional area will be measured to estimate the volume of the gastric content.

Study Arms (6)

Sequence 123

EXPERIMENTAL

In this study arm the following sequence of interventions will be administered: upon first study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon second study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon third study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution).

Dietary Supplement: Intervention #1: ProvideXtra DrinkDietary Supplement: Intervention #2: Fresubin Energy DrinkDietary Supplement: Intervention #3: Generic Glucose Solution

Sequence 132

EXPERIMENTAL

In this study arm the following sequence of interventions will be administered: upon first study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon second study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution). upon third study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink).

Dietary Supplement: Intervention #1: ProvideXtra DrinkDietary Supplement: Intervention #2: Fresubin Energy DrinkDietary Supplement: Intervention #3: Generic Glucose Solution

Sequence 213

EXPERIMENTAL

In this study arm the following sequence of interventions will be administered: upon first study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon second study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon third study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution).

Dietary Supplement: Intervention #1: ProvideXtra DrinkDietary Supplement: Intervention #2: Fresubin Energy DrinkDietary Supplement: Intervention #3: Generic Glucose Solution

Sequence 231

EXPERIMENTAL

In this study arm the following sequence of interventions will be administered: upon first study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon second study session, intervention #3 will be administered (Dietary Supplement: Fresubin Energy Drink). upon third study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink).

Dietary Supplement: Intervention #1: ProvideXtra DrinkDietary Supplement: Intervention #2: Fresubin Energy DrinkDietary Supplement: Intervention #3: Generic Glucose Solution

Sequence 312

EXPERIMENTAL

In this study arm the following sequence of interventions will be administered: upon first study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution). upon second study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink). upon third study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink).

Dietary Supplement: Intervention #1: ProvideXtra DrinkDietary Supplement: Intervention #2: Fresubin Energy DrinkDietary Supplement: Intervention #3: Generic Glucose Solution

Sequence 321

EXPERIMENTAL

In this study arm the following sequence of interventions will be administered: upon first study session, intervention #3 will be administered (Dietary Supplement: Generic Glucose Solution). upon second study session, intervention #2 will be administered (Dietary Supplement: Fresubin Energy Drink). upon third study session, intervention #1 will be administered (Dietary Supplement: ProvideXtra Drink).

Dietary Supplement: Intervention #1: ProvideXtra DrinkDietary Supplement: Intervention #2: Fresubin Energy DrinkDietary Supplement: Intervention #3: Generic Glucose Solution

Interventions

Fasted subjects will be offered 200 ml of ProvideXtra and will be asked to ingest it at a comfortable rate. Subsequent gastric ultrasound examinations will be performed half-hourly (up to 6 hours) to determine the volume of the gastric contents. The intervention ends when the stomach appears to be empty again on ultrasound.

Also known as: fat-free, high-calorie drink containing hydrolised vegetal protein
Sequence 123Sequence 132Sequence 213Sequence 231Sequence 312Sequence 321

Fasted subjects will be offered 200 ml of Fresubin Energy Drink and will be asked to ingest it at a comfortable rate. Subsequent gastric ultrasound examinations will be performed half-hourly to determine the volume of the gastric contents. The intervention ends when the stomach appears to be empty again on ultrasound.

Also known as: high-calorie drink without fiber
Sequence 123Sequence 132Sequence 213Sequence 231Sequence 312Sequence 321

Fasted subjects will be offered the glucose solution and will be asked to ingest it at a comfortable rate. Subsequent gastric ultrasound examinations will be performed half-hourly (up to 6 hours) to determine the volume of the gastric contents. The intervention ends when the stomach appears to be empty again on ultrasound.

Also known as: Solution reconstituted form 75 g glucose and 300 ml water
Sequence 123Sequence 132Sequence 213Sequence 231Sequence 312Sequence 321

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 1 and 2

You may not qualify if:

  • Allergy or intolerance to any of the study products or the ingredients
  • Previous esophageal, gastric, or duodeno-pancreatic surgery
  • Gastric banding or large hiatal hernia
  • mmobility
  • Contraindication to right lateral positioning
  • Gastrointestinal diseases and disturbances
  • Participation in another, possibly interfering study
  • Diabetes mellitus
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Vienna

Vienna, 1090, Austria

Location

Related Publications (5)

  • Smith I, Kranke P, Murat I, Smith A, O'Sullivan G, Soreide E, Spies C, in't Veld B; European Society of Anaesthesiology. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011 Aug;28(8):556-69. doi: 10.1097/EJA.0b013e3283495ba1.

    PMID: 21712716BACKGROUND
  • Tacken MCT, van Leest TAJ, van de Putte P, Keijzer C, Perlas A. Ultrasound assessment of gastric volumes of thick fluids: Validating a prediction model. Eur J Anaesthesiol. 2021 Dec 1;38(12):1223-1229. doi: 10.1097/EJA.0000000000001465.

    PMID: 33606419BACKGROUND
  • Perlas A, Mitsakakis N, Liu L, Cino M, Haldipur N, Davis L, Cubillos J, Chan V. Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination. Anesth Analg. 2013 Feb;116(2):357-63. doi: 10.1213/ANE.0b013e318274fc19. Epub 2013 Jan 9.

    PMID: 23302981BACKGROUND
  • Perlas A, Arzola C, Van de Putte P. Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review. Can J Anaesth. 2018 Apr;65(4):437-448. doi: 10.1007/s12630-017-1031-9. Epub 2017 Dec 11.

    PMID: 29230709BACKGROUND
  • Van de Putte P, Perlas A. Ultrasound assessment of gastric content and volume. Br J Anaesth. 2014 Jul;113(1):12-22. doi: 10.1093/bja/aeu151. Epub 2014 Jun 3.

    PMID: 24893784BACKGROUND

MeSH Terms

Interventions

Dietary FiberGlucoseWater

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesHexosesMonosaccharidesSugarsHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Andreas Duma, MSc

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: 3 interventions will be administered in fasted healthy volunteers in a random sequence on 3 different days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 28, 2022

First Posted

April 18, 2022

Study Start

March 28, 2022

Primary Completion

May 18, 2022

Study Completion

June 1, 2022

Last Updated

August 12, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

IPD will be accessed by the PI upon request.

Shared Documents
CSR, ANALYTIC CODE
Time Frame
Data will be available from the PI 10 years after study completion.

Locations